Skip to content

Randomized Controlled Trials Comparing Clinical Outcome of Paraspinal Mini-Tubular Microdiscectomy Versus Percutaneous Transforaminal Endoscopic Discectomy for Lumbar Disk Herniation

Randomized Controlled Trials Comparing Clinical Outcome of Paraspinal Mini-Tubular Microdiscectomy Versus Percutaneous Transforaminal Endoscopic Discectomy for Lumbar Disk Herniation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015727
Enrollment
Unknown
Registered
2018-04-17
Start date
2018-04-17
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation with Radiculopathy

Interventions

PMTM Group:Paraspinal Mini-Tubular Microdiscectomy
PTED Group:Percutaneous Transforaminal Endoscopic Discectomy

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-70 years; (2) obvious symptoms of lumbar/leg pain, more than 3 months with/without conservative treatment; (3) supine straight leg raise was less than 50 degree; (4) all patients underwent MRI and CT to confirm that the posterolateral lumbar intervertebral disc herniation in L3/4, L4/5 or L5/S1, and was consistent with the corresponding neurological symptoms; (5) lumbar X-ray (positive side, double oblique, over-extended & flexion), no segmental lumbar instability; (6) informed consent of the patient.

Exclusion criteria

Exclusion criteria: (1) women who are pregnant or lactating women, and those whose ß-HCG overhigh; (2) surgical history of lumbar segment; (3) cauda equina syndrome; (4) spondylolisthesis or degenerative spondylolisthesis; (5) the central type and lateral spinal stenosis; (6) failure to follow up the follow-up of the program requirements, or the researchers believe that participants will participate in the study to increase the risk; (7) failing to provide written informed consent, or failing to comply with the pilot scheme; (8) the expected survival time is less than one year; (9) plan for immigration or language communication disorders within one year; (10) other serious physical or psychological diseases are not suitable for surgery; (11) participating in other clinical trials; (12) patients with rheumatic immune diseases that may cause similar symptoms; (13) it is not suitable for special examiners such as MRI and CT enhancement.

Design outcomes

Primary

MeasureTime frame
Oswestry disable index;

Secondary

MeasureTime frame
VAS-lumbar;VAS-leg;japanese orthopeadic association score;operation time;X-ray exposure time;bleeding volume;surgical cost;CK-MM;length of stay;

Countries

China

Contacts

Public ContactChun-mei Chen

Fujian Medical University Union Hospital Neurosurgery Department

cmchen2009@hotmail.com+86 13509339040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026